Eurofins Viracor
eurofins-viracor.com
Health Care
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Ampersand Capital PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Eurofins Viracor Expands Cytokine Testing Menu with Plasma Assays for CXCL9, CXCL10, and IL-18 to Support Immune Monitoring in Transplant and Immunocompromised Patients
Read more
Report
Eurofins Viracor Launches ExPeCT anti-CD19 (obe-cel) CAR T-Cell Assay to Advance Proactive Monitoring in Next-Generation Immunotherapy
Read more
Report
Eurofins Viracor Launches Assays for Pneumococcal Antibody Detection, Expanding Serotype Coverage to Support Immunocompromised Patient Care
/PRNewswire/ -- Eurofins Viracor announces the launch of a multiplexed bead-based assay to detect IgG responses to currently available pneumococcal vaccines,...
Read more
Report
Eurofins Viracor
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Eurofins Viracor reflects the research output of authors from Eurofins Viracor who published articles in the 145 journals included in
Read more
Report
Eurofins Viracor Launches New Quantitative Real-Time PCR Testing for Rapid and Accurate Detection of Life-Threatening Dimorphic Fungi
Eurofins Viracor announced today the launch of its new quantitative real-time PCR assays for dimorphic fungi, a significant advancement in the rapid and accurate diagnosis of infections caused by Blastomyces spp., Histoplasma spp., Coccidioides spp., and
Read more
Report
Eurofins Viracor Launches New Quantitative PCR Assay for Chagas Disease (T. cruzi) Diagnosis Newswise
Eurofins Viracor, LLC, a leading provider of specialty diagnostic testing and part of the global network of Eurofins companies, is pleased to announce the launch of an innovative quantitative PCR assay for the detection of Trypanosoma cruzi (T. cruzi), th
Read more
Report